Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.990
-0.010 (-0.50%)
May 5, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Stem Cell Treatments
9.00K
Log In
Log In
Log In
Log In
Upgrade
Stem Cell Treatments Growth
-89.84%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
9.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-89.84%
Log In
Log In
Log In
Log In
Upgrade